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Abstract
Purpose. The influence of initial inadequate excision (IIE) of soft tissue sarcoma (STS) on local control and overall survival
is not well established. It is generally believed that an IIE may have a negative impact on both, despite subsequent treatment
by radical surgery and radiotherapy. However, data on local recurrence-free survival/overall survival are conflicting and there
are no data on the effect of IIE on overall survival.
Patients and methods. A retrospective analysis was made of 86 patients with soft tissue sarcoma of the extremities and trunk
after an IIE had been performed due to inappropriate work-up. The minimal follow-up was 7 years. Specimens of the
subsequent radical resection were evaluated for residual tumor, grade of tumor and complications of IIE. Endpoints were
recurrence-free survival and overall survival.
Results. Specimens of the subsequent radical resection showed residual tumor in 66 patients (77%). The most common
complication after IIE was hematoma. In both univariate and multivariate analyses, grade II/III tumors and complications
after IIE are significant negative prognostic factors for local recurrence-free survival (P¼0.008 and P¼0.002, respectively,
in the Cox model). For this survival, three prognostic groups could be formed based on grade, or presence or absence of
complications. Adjuvant radiotherapy did not change the rate of local recurrence-free survival. For overall survival, only
tumor grade is a significant factor (log-rank test).
Conclusion. This retrospective study shows that complications associated with an IIE have a significant negative effect on
local control, but not on overall survival, because IIE is often the result of inappropriate work-up before surgery. For better
diagnosis and therapy STS should be treated in specialized centers.
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Introduction
Soft tissue sarcoma (STS) is a group of anatomical
and histological diverse malignancies of mesen-
chymal tissue. STS is a rare condition: in the USA
there are about 7000 new cases and 4300 deaths
each year.
1
Local control of STS mainly depends on the
extent of surgical treatment. The most effective local
control is achieved by resection of the tumor with
clear margins; however, the definition of radical
resection is still debated. The definition varies from
wide resection to compartment resection and myect-
omy, with less radical resections being defined as
marginal or intralesional ones. The local recurrence
rate of these latter resections ranges from 60 to 95%,
whereas the local recurrence rate of radical resection
ranges from 5 to 30%.
2–4 When a radical resection
cannot be achieved, radiotherapy can improve the
local control rate, but will rarely match the better rate
of radical resections. Improved local control rate is
not reflected in a better disease-specific survival.
5
Brachytherapy is reported to achieve better local
control than conventional radiotherapy, especially
for high-grade sarcomas.
6
Other factors influencing the local control rate are
tumor size, depth, retroperitoneal and visceral
localizations, and histological grade.
7
In addition, factors such as age or specific
histological types have occasionally been reported.
8,9
In practice, a substantial number of patients
undergo a marginal resection because the tumor
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DOI: 10.1080/13577140310001650321has not been recognized as a STS. After the
pathological diagnosis of STS is established, a
subsequent treatment must be performed, preferably
by a radical resection whether or not in combination
with radiotherapy. There are few data on the effect of
these unplanned initial inadequate resections (IIE)
with no clear margins on local recurrence rate,
9–11
and no data at all on survival. This issue also has
been studied, with conflicting results, only in patients
with an incisional biopsy, a problem that may be
closely related to an IIE.
3,12
Patients and methods
All records of 263 patients with STS referred for
surgery to the University Hospital Rotterdam/Daniel
den Hoed Cancer Center between 1986 and 1993
were reviewed. Excluded from this study were those
patients with a local recurrence and/or distant
metastases at time of referral. Retrospectively, those
patients were identified who had a previous irradical
resection for diagnostic reasons, which could not be
classified as an incisional biopsy. Only patients with
STS in the limbs, girdles and trunk were entered in
this study because, in these patients, a radical treat-
ment (radical resection, marginal resection with
radiotherapy or amputation) is always possible. Small
superficial tumors ( 5cm) were also excluded.
Pathological examination was carried out in our
hospital, on all resected specimens of all patients,
also when the initial surgery was performed in
another hospital. Excluded from this study were
those pathological subtypes of STS that need a
non-surgical approach as the first-line treatment
(e.g., small round-cell sarcomas such as Ewing
sarcoma), or subtypes with a specific biological
behavior such as borderline tumors (e.g., aggressive
fibromatosis and desmoids), because they do not
give distant metastases.
For statistical reasons it was decided to include
only patients treated before 1993, thus assuring a
follow-up period of at least 7 years in all patients.
In our records we found 86 patients (32.7% of all
patients referred for treatment) fulfilling the above-
mentioned criteria. The following data were collec-
ted: age at the time of diagnosis, tumor site, date and
type of initial surgery (excision or debulking),
complications of this procedure (hematoma, infec-
tion), type of incision, residual tumor seen on CT or
MRI after initial surgery, date and type of subse-
quent definitive surgery, whether definitive surgery
was preceded by an isolated limb perfusion, and
whether definitive surgery was followed by adjuvant
radiotherapy and/or adjuvant chemotherapy.
Histopathological work-up included: whether a
macro- or microscopical residual tumor was seen at
pathological examination, total diameter of the
tumor, including the size of the IIE, and pathological
type and grade of tumor. Furthermore, the
complexity of the definitive surgical procedure
was evaluated compared with the one surgical
procedure that would have been performed after an
initial appropriate preoperative work-up. Finally,
data on morbidity, local control and survival were
noted.
Statistical analysis
The potential prognostic factors underwent
univariate analysis with respect to three endpoints:
time to death, time to local recurrence and time to
distant metastases. Local recurrence-free survival
was calculated for those patients alive at 2, 5 and
10 years. Log-rank tests and Kaplan-Meier survival
analyses were used for all factors and endpoint
combinations for all 86 studied patients. In multi-
variate analysis, only local control was studied using
the Cox proportional hazards model. Based on
the results of the multivariate analysis we formed
three prognostic groups (good, moderate and poor
prognosis).
Results
In this series of 86 patients, there were 47 males and
39 females (age range 17–77 years). The tumor was
located in the lower limb in 39 cases (45%), the
upper limb in 17 (20%), the trunk in 19 (22%) and
in the girdles in 11 (13%). There were 21 superficial
tumors larger than 5cm and 65 deep, subfacial
tumors.
In 51 patients (60%), the operation was consid-
ered to be an excisional biopsy. In the remaining 35
patients (40%), only a gross debulking of the tumor
was performed.
At presentation in our hospital, a hematoma
was seen in 20 (23%) of the 86 patients. In three
patients, a wound infection at presentation needed
immediate drainage, and another three patients were
treated by antibiotics. Transverse scars were seen in
15 patients.
Within 3–4 weeks after referral, a CT scan or MRI
was performed for local staging. In 40 patients
(46%), no residual tumor could be found. In the
remaining 46 patients (54%), there were changes
in the surgical field that could not be explained by
the previous surgery alone, with a strong suspicion of
macroscopic tumor remnant being present. In the
resected specimens, residual tumor was found in 66
patients (77%).
On pathological examination, liposarcoma was the
most common subtype and was found in 17 patients
(20%), all other types represented less than 10% of
the STS.
The tumor was graded according to Trojani as
follows: grade I in 28 patients (33%), grade II in
44 (51%) and grade III in 14 (16%).
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patients and T2 (>5cm) in 45 patients.
In the absence of distant metastases, all patients
underwent a radical treatment for their primary
lesion: whenever feasible, a radical resection was
performed (n¼45) and in other cases a less radical
resection with adjuvant radiotherapy (n¼33). In
our institute, a radical resection is defined as a
resection of the tumor with a free margin of at least
1cm at pathological examination, or less than 1cm
when, at that margin, fascia, periostium or perichon-
drium is present. Four patients did not receive
further treatment after IIE and another four patients
received only radiotherapy.
Radiotherapy was delivered to the target area
(compartment or field round the tumor bed with a
margin of 5–7cm length and 2cm transverse) at a
dosage of 50Gy in 25 fractions, with a boost on the
tumor bed of 10Gy in five fractions. The total
dosage was increased to 70Gy in cases of limited
resection margins.
In five cases, an isolated limb perfusion was
the initial treatment in order to prevent amputation
or major functional morbidity. Five patients
were treated in the context of the EORTC protocol
10863 with neoadjuvant chemotherapy (doxorubicin
50mg/m
2 and ifosfamide 5mg/m
2 i.v.q. 3 weeks,
three courses) and were excluded from multivariate
analysis for local recurrence rate because they were
recognized as high-risk patients.
In 50% of patients, the definitive surgery was
considered to be more complex and resulted in
more morbidity than could be expected had the
tumor been diagnosed and treated in the proper way
at first presentation. In 71 patients (82%), the
postoperative course was uneventful.
All patients were followed for 7 years or longer.
Of the total group, 25 patients (29%) developed a
local recurrence and 28 patients (33%) distant
metastases; 14 patients (16%) had both local and
distant recurrent disease.
At the close of the study, 52 patients (60%)
were still alive without any evidence of STS and
four patients (5%) were alive with evidence of
recurrent tumor. A total of 30 patients (35%) had
died, five of whom died from intercurrent diseases.
Table 1 gives data on overall survival, local
recurrence-free and distant recurrence-free survival
at 2, 5 and 10 years follow-up.
Table 2 lists the prognostic parameters investi-
gated and Table 3 gives the results of the univariate
analyses.
Table 2. Study parameters of 86 patients with an unplanned excision of soft tissue sarcoma
Potential prognostic factors
1. Age at the date of the first operation
2. Gender
3. Localization of the primary: lower limb, upper limb, trunk (abdominal wall, back, and buttock) and girdles (axilla
and groin)
4. Complication after the first operation: hematoma
5. Definitive surgery: radical resection þ/  isolation perfusion or amputation, less radical resection þ/  isolation perfusion
and radiotherapy, no therapy and radiotherapy alone
6. The definitive surgical procedure was more complex than could be expected had proper diagnosis and treatment
taken place initially. Also, that adjuvant radiotherapy could be avoided in case of residual macroscopical tumor or
microscopical high-grade tumor)
6. Tumor diameter before any treatment
7. Histopathological diagnosis (liposarcoma, all other types of sarcoma)
8. Grade according to Trojani
9. Macroscopical residual tumor seen at CT scan or MRI after initial surgery
10. Microscopical residual tumor found only at histopathological examination
11. Data of follow-up (date of local recurrence and/or distant metastases, last date of follow-up and survival status)
Follow-up Data
1. Survival status and date of death or last date of follow-up
2. Local recurrence status and date of local recurrence (if occurred)
3. Distant metastases status and date of distant metastases (if occurred)







2 years 86 86 85
5 years 75 74 74
10 years 55 65 56
Initial inadequate excision 161The Cox proportional hazards model was used to
determine local recurrence-free survival. Only comp-
lication (P¼0.002) and tumor grade (P¼0.008)
appeared tobeindependent prognosticfactorsforthis
endpoint. Based on these two factors, three prognos-
tic groups were created. These groups (defined as
good, moderate and poor) are described in Table 4
and the local recurrence-free survival is shown in
Figure 1.
Table 5 presents data on the local recurrence-free
survival for the three prognostic groups, with or
without radiotherapy.
Fig. 1. Local recurrence-free survival curves of 81 patients with initial irradical excision for soft tissue sarcoma: group I, good prognosis
(n¼23); group II, moderate prognosis (n¼43); group III, poor prognosis (n¼15).
Table 3. Data (P values) on the potential prognostic factors of initial irradical excision of soft tissue sarcoma in







Age at diagnosis 0.08 0.16 0.43
Gender 0.40 0.27 0.11
Time to symptoms 0.46 0.99 0.73
Localization 0.12 0.39 0.87
Complication 0.16 0.002 0.048
Definitive treatment 0.54 0.006 0.07
Complexity 0.16 0.002 0.048
Residual tumor
Macroscopic 0.18 0.02 0.12
Microscopic 0.31 0.17 0.32
Diameter 0.18 0.52 0.25
Pathology 0.43 0.46 0.17
Grade 0.01 0.004 0.0003
Table 4. Prognostic subgroups of patients with an initial irradical excision of soft tissue sarcoma (n¼81)
Local recurrence-free survival (%)
Group 2 years 5 years 10 years
I( n¼23) Good prognosis 100 100 86
II (n¼43) Moderate prognosis 93 79 86
III (n¼15) Poor prognosis 67 37 37
Group I, grade I and no complication; group II, grade II/III or complication; and group III, grade II/III and
complication.
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Resection of STS with inadequate margins is
considered the most negative prognostic factor in
local recurrence-free survival. As early as 1986,
Suit and Tepper concluded that local recurrence
rates vary according to the initial surgical procedure,
and that improved local control correlates with
better survival.
13 However, data from many large
studies do not support this conclusion and do not
identify local recurrence as an independent unfavor-
able prognostic factor for survival. In all studies,
tumor grade was the most important and dominant
prognostic factor.
14,15
Improvement of preoperative imaging by CT
and MRI and improvement of treatment modalities
(e.g., surgery alone or in combination with radio-
therapy and chemotherapy including regional
isolated limb perfusion) have increased the local
control rate to about 85%.
16,17
All patients who have undergone an IIE for
STS are candidates for a second operation in order
to achieve adequate surgical margins. A poorly
performed open biopsy or IIE can change the
definitive surgical treatment in at least 30%.
18,19
In the recent literature, we found no data to show
that patients with a radical resection as first
treatment will have a better local recurrence-free
survival than those with a radical resection after IIE
(so-called ‘whoops operation’). Nor could we find
factors in the latter group with an adverse effect
on overall survival.
In some series, the systematic use of an incisional
biopsy is reported to be the cause of higher local
recurrence rates.
20 However, Collin et al. could
not confirm this statement.
12 Of note is a recent
study from the Memorial Sloan-Kettering Cancer
Center, which reports better overall survival in
patients with re-resection after previous resection
elsewhere, compared with one definitive resection
in the Cancer Center as primary treatment; this
is especially significant for high-grade STS.
21
The authors then concluded that, where possible,
re-resection should be liberally applied in patients
with primary extremity STS.
For the reasons mentioned above, we studied a
group of patients who had undergone an IIE
elsewhere and who were referred to our center for
definitive treatment.
After 5 years, the overall survival was 75%, the
local recurrence-free survival was 74% and the
distant recurrence-free survival was 74%, these
percentages correspond with data in literature.
Two retrospective studies, similar to ours, also
reported the problem of unplanned excision. In
1996, Goodlad et al. studied 95 patients but did
not report morbidity and follow-up data,
10 and
Noria et al. investigated 65 patients but included
only extremity sarcomas without evidence of macro-
scopical tumor before second surgery.
11 We found
residual disease in 66 patients (77%), which is
higher than reported in the latter two series,
i.e., 59 and 35%, respectively. In 20 of the 66
patients in our series and in 25 of the 56 patients
in the Goodlad et al. series, the residual disease
was found only at pathological examination. In
another study by Giuliano and Eilber, the number
of patients with residual bulky disease was the same
as those with residual disease found only at
pathology.
22
Because these earlier studies give no information
on the postoperative course and complications after
IIE no comparison can be made with our results,
nor was any information given about the influence
of the first operation on the extent of the definitive
resection and or the number of patients who
subsequently received adjuvant radiotherapy.
When comparing the definitive surgical procedure
with the one procedure that might have been per-
formed after an appropriate preoperative work-up
we realize that ‘more complex’ is a subjective
criterion. Therefore, we give an example to explain
what is intended by ‘more complex surgery’: for
instance, a transverse scar in the extremity can lead
Table 5. Local recurrence-free survival for three prognostic subgroups with or without radiotherapy (n¼81)
Local recurrence-free survival (%)
2 years 5 years 10 years
Group without radiotherapy
I( n¼18) Good prognosis 100 100 80
II (n¼21) Moderate prognosis 100 94 94
III (n¼6) Poor prognosis 66 50 50
Group with radiotherapy
I( n¼5) Good prognosis 100 100 100
II (n¼22) Moderate prognosis 86 65 47
III (n¼9) Poor prognosis 66 26 –
Group I, grade I and no complication; group II, grade II/III or complication; and group III, grade II/III and
complication.
Initial inadequate excision 163to difficulty in resecting the scar and the former
surgical field and a skin graft may be used to avoid
too much traction; Mankin et al. also addressed
this problem.
23 Inappropriate placement of the
biopsy scar conflicts with the definitive resection.
The surgeon involved in the definitive treatment
should also perform the biopsy, and this may
explain the better outcomes in specialized centers.
24
The group of patients studied by Tovnik with high
grade deep-seated sarcomas referred with untouched
lesions, had a local recurrence rate of 25% compared
with 33% for those referred after biopsy or incom-
plete excision (P¼0.2).
25 In these patients there
was also a tendency towards more inadequate final
margins, but this was counteracted by increased
use of radiotherapy. Adjuvant radiotherapy can
introduce co-morbidity, especially in the neighbor-
hood of the joints. However, in our three subgroups
of patients we cannot conclude that radiotherapy
contributes to a better local recurrence-free survival.
Open biopsy has been associated with a higher
rate of local recurrence (36%) compared to needle
or no biopsy (24%, P¼0.04).
25
In our series, 43 of the patients (50%) were
subjected to a more complex surgical procedure due
to subsequent treatment; this in contrast to initially
considering the extent of primary local tumor on
MRI or CT followed by a proper surgical treatment,
as proposed by our national guidelines.
26
The data from this analysis suggest that posto-
perative complications of IIE significantly increase
the rate of local recurrence; however, this increased
rate does not influence overall survival. This
supports the hypothesis that local recurrence is an
independent endpoint not related to survival, as
reported in recent large studies,
14,15,22 which is in
contrast to the first report dealing with this subject.
27
In our series, 63 patients had no complications and
20 patients (23.2%) suffered from a hematoma.
Conclusions
Our retrospective study does not indicate that IIE
has a negative impact on overall survival. With
respect to local recurrence, it is shown that 19%
of the 86 patients had a bad prognosis due to the
grade of the tumor and complications after IIE.
These findings are similar to those reported by the
Scandinavian Sarcoma Group: inadequate surgical
margins contribute to a higher local recurrence rate
but not to a higher rate of distant metastases.
27 In
STS, tumor grade is a factor, which cannot be
influenced, whereas complications after IIE can
be avoided because they are related to the surgery.
This situation can be improved by systematically
referring patients with STS to sarcoma units where
a proper invasive diagnostic procedure can be done
after adequate imaging. In almost all cases, even an
incisional biopsy can be avoided by performing
a thru-cut biopsy or fine needle aspiration.
28 In
those cases where an incisional biopsy cannot be
avoided, the procedure should be performed under
strict conditions and according to well-described
guidelines.
18,23,29
In a recent review of the literature, Spiro et al.
concluded that negative surgical margins achieve
the best local control. Less important are other
factors such as tumor size, pathological grade,
histopathology and concomitant chemotherapy.
31
The (unplanned) initial irradical resection should
be added to this list.
Acknowledgment
Thanks to Mrs Laraine Visser for preparing the
English manuscript.
References
1. Cancer facts and figures. Atlanta GA: American Cancer
Society, 1999.
2. Shiu MH, Castro EB, Hajdu SI, Fortner JC. Surgical
treatment of 297 soft tissue sarcomas of the lower
extremity. Ann Surg 1975; 182: 597–602.
3. Markhede G, Angervall L, Stener B. A multivariate
analysis of the prognosis after surgical treatment
of malignant soft tissue tumors. Cancer 1982; 9:
1721–33.
4. Rydholm A, Ro ¨o ¨ser B. Surgical margins for soft tissue
sarcoma. J Bone Joint Surg 1987; 69A: 1074–8.
5. Rosenberg SA, Tepper J, Glatstein E, Costa J,
Baker A, Brennan MJ, DeMoss EV, Seipp C,
Sindelar WF, Sugarbaker P, Wesley R. The treatment
of soft tissue sarcomas of the extremities: prospective
randomized evaluations of (1) limb sparing surgery
plus radiation therapy compared with amputation
and (2) the role of adjuvant chemotherapy. Ann Surg
1982; 196: 305–15.
6. Pisters PWT, Harrison LB, Leung DHY,
Woodruff JM, Casper ES, Brennan MF. Long-term
results of a prospective randomized trial of adjuvant
brachytherapy in soft tissue sarcoma. J Clin Oncol
1996; 14: 859–68.
7. Lewis JJ, Brennan MF. Soft tissue sarcomas. Curr Prob
Surg 1996; 33: 817–72.
8. Coindre JM, Terrier P, Bui N, Barichou F, Collin F,
Le Doussal V, Mandard AM, Vilain MO,
Jacquemier J, Duplay H, Sastre X, Barlier C,
Henri-Amar M, Mace-Lesech J, Contesso G.
Prognostic factors in adult patients with locally
controlled soft tissue sarcoma; a study of 546 patients
from the French Federation of Cancer Centers
Sarcoma Group. J Clin Oncol 1996; 14: 869–77.
9. Pisters PWT, Leung DHY, Woodruff J, Shiu W,
Brennan MF. Analysis of prognostic factors in 1041
patients with localized soft tissue sarcomas of the
extremities. J Clin Oncol 1996; 14: 1679–89.
10. Goodlad JR, Fletcher CD, Smith MA. Surgical
resection of primary soft-tissue sarcoma. Incidence of
residual tumour in 95 patients needing re-excision
after local resection. J Bone Joint Surg Br 1996; 78:
658–61.
11. Noria S, Davis A, Kandel R, Levesque J, O’Sullivan B,
Wunder J, Bell R. Residual disease following
unplanned excision of soft-tissue sarcoma of an
extremity. J Bone Joint Surg Am 1996; 78: 650–655.
164 A.N. van Geel et al.12. Collin C, Hajdu SI, Godbold J, Shiu MH,
Hilaris BI, Brennan MF. Localized, operable soft
tissue sarcoma of the lower extremity. Arch Surg 1986;
121: 1425–33.
13. Suit HD, Tepper JE. Impact of improved local control
on survival in patients with soft tissue sarcoma. Int J
Radiat Oncol Biol Phys 1986; 12: 699–700.
14. Stotter AT, A’Hearn RP, Fisher C. The influence of
local recurrence of extremity soft tissue sarcoma on
metastases and survival. Cancer 1990; 65: 1119–29.
15. Gustafson P, Rooser B, Rydholm A. Is local recur-
rence of minor importance for metastases in soft tissue
sarcoma? Cancer 1991; 67: 2083–6.
16. Eilber FR, Guiliano AE, Huth JF, Morton DL.
A randomized prospective trial using postoperative
adjuvant chemotherapy (adriamycin) in high grade
extremity soft tissue sarcoma. Am J Clin Oncol 1988;
11: 39–45.
17. Eggermont AMM, Schrafford Koops H, Klausner JM,
Kroon BBR, Schlag PM, Lienard D, van Geel AN,
Hoekstra HJ, Meller I, Nieweg OE, Kettelhack C,
Ben-ari G, Pector JC, Lejeune FJ. Isolated limb
perfusion with tumor necrosis factor and melphalan
for limb salvage in 186 patients with advanced soft
tissue extremity sarcoma. Ann Surg 1996; 224:
756–65.
18. Simon MA. Current concepts review: biopsy of
muculoskeletal tumors. J Bone Joint Surg Am 1982;
64: 1253–7.
19. Mankin HJ, Lange TA, Spanier SS. The hazards of
biopsy in patients with malignant bone and soft tissue
tumors. J Bone Joint Surg Am 1982; 64A: 1121–7.
20. Rydholm A, Gustafson P, Roo ¨ser B, Willen H,
Akerman M, Herlin K, Alvegard T. Limb sparing
surgery without radiotherapy based on anatomic
location of soft tissue sarcoma. J Clin Oncol 1991; 9:
1757–65.
21. Lewis JJ, Leung D, Espat J, Woodruff JM,
Brennan MF. The effect of re-resection in extremity
soft tissue sarcoma. Sarcoma 2001; 5: 41.
22. Giuliano AE, Eilber FR. The rationale for planned
reoperation after unplanned total excision of soft
tissue sarcoma. J Clin Oncol 1985; 3: 1344–8.
23. Mankin HJ, Mankin CJ, Simon MA. The hazards
of the biopsy, revisted. J Bone Joint Surg 1996; 78:
656–63.
24. Yasko AW, Reece GP, Gilles TA, Pollock RE. Limb-
salvage strategies to optimalize quality of life: the
M.D. Anderson Cancer Center experience. CA Cancer
J Clin 1997; 47: 226–38.
25. Tovnik CS. Local recurrence of soft tissue sarcoma.
A Scandinavian Sarcoma Group project. Primary
treatment and local recurrence. Acta Orthop Scand
2001; 72(Suppl 300): 13–6.
26. van Geel AN, van Unnik JAM, Keus R. Diagnosis
and treatment of soft tissue tumours: the Dutch
nationwide accepted consensus. Sarcoma 1998; 2:
183–91.
27. Trovnik CS, Bauer HCF, Alvega ¨a ¨rd TA, Anderson H,
Blomquist C, Berlin O ¨ , Gustafson P, Saeter G,
Wallo ¨e A. Surgical margin, local recurrence and
metastases in soft tissue sarcoma: 559 surgically
treated patients from the Scandinavian Sarcoma
Group Register. Eur J Cancer 2000; 36: 710–6.
28. Heslin M, Lewis J, Woodruff J, Brennan M. Core
needle biopsy for diagnosis of extremity soft tissue
sarcoma. Ann Surg Oncol 1997; 4: 425–31.
29. Hoeber I, Spillane AJ, Fisher C, Meiron Thomas J.
Accuracy of biopsy techniques for limb and girdle
soft tissue tumours. Ann Surg Oncol 2001; 8: 80–7.
30. Spiro IJ, Gebhardt MC, Jennings LC, Mankin HJ,
Harmon DC, Suit HD. Prognostic factors for local
control of sarcomas of the soft tissues managed by
radiation and surgery. Semin Oncol 1997; 24: 540–6.
Initial inadequate excision 165